PTH: a future role in the management of osteoporosis?

PTH: a future role in the management of osteoporosis?

Bibliografski detalji
Glavni autor:	Reeve, J
Format:	Journal article
Jezik:	English
Izdano:	1996

Slični predmeti

Further observations on the treatment of involutional osteoporosis with hPTH 1–34; The effects of added estrogens
od: Reeve, J, i dr.
Izdano: (1986)

Teriparatide (rhPTH 1-34) for the treatment of osteoporosis.
od: Ebeling, P, i dr.
Izdano: (2003)

Economic evaluation of parathyroid hormone (PTH) in the treatment of osteoporosis in postmenopausal women.
od: Lundkvist, J, i dr.
Izdano: (2006)

hPTH 1-34 treatment of osteoporosis with added hormone replacement therapy: biochemical, kinetic and histological responses.
od: Reeve, J, i dr.
Izdano: (1991)

A short-cycle ADFR regimen using parathyroid peptide hPTH 1–34 in idiopathic osteoporosis
od: Reeve, J, i dr.
Izdano: (1986)

Combination Therapy of PTH and Antiresorptive Drugs on Osteoporosis: A Review of Treatment Alternatives
od: Chenggui Zhang, i dr.
Izdano: (2021-01-01)

La PTH 1-84 en el tratamiento de la osteoporosis
od: Sosa Henríquez M, i dr.
Izdano: (2010-07-01)

The relationship between changes in femoral bone density and calcium balance in patients with involutional osteoporosis treated with human parathyroid hormone fragment (hPTH 1–34)
od: Hesp, R, i dr.
Izdano: (1981)

Fisiopatología de la osteoporosis y mecanismo de acción de la PTH
od: González Macias J, i dr.
Izdano: (2010-05-01)

Role of PTH in the Renal Handling of Phosphate
od: Rebecca D. Murray, i dr.
Izdano: (2015-08-01)

Peptide Engraftment on PEGylated Nanoliposomes for Bone Specific Delivery of PTH (1-34) in Osteoporosis
od: Sagar Salave, i dr.
Izdano: (2023-02-01)

Osteoporosis: cause and management
od: Reeve, J, i dr.
Izdano: (1987)

Calcium-47 kinetic measurements of bone turnover compared to bone histomorphometry in osteoporosis: the influence of human parathyroid fragment (hPTH 1-34) therapy.
od: Reeve, J, i dr.
Izdano: (1981)

Optimization of PTH/PTHrP Hybrid Peptides to Derive a Long‐Acting PTH Analog (LA‐PTH)
od: Hiroshi Noda, i dr.
Izdano: (2020-07-01)

Multi-faced profile of PTH excess-related secondary osteoporosis: customized therapy and rehabilitation approach
od: Claudiu Nistor, i dr.
Izdano: (2024-09-01)

Nasal Administration and Plasma Pharmacokinetics of Parathyroid Hormone Peptide PTH 1-34 for the Treatment of Osteoporosis
od: Richard G. Pearson, i dr.
Izdano: (2019-06-01)

Modeling of Oxidized PTH (oxPTH) and Non-oxidized PTH (n-oxPTH) Receptor Binding and Relationship of Oxidized to Non-Oxidized PTH in Children with Chronic Renal Failure, Adult Patients on Hemodialysis and Kidney Transplant Recipients
od: Berthold Hocher, i dr.
Izdano: (2013-07-01)

Treatment of osteoporosis with parathyroid peptide (hPTH 1-34) and oestrogen: increase in volumetric density of iliac cancellous bone may depend on reduced trabecular spacing as well as increased thickness of packets of newly formed bone.
od: Bradbeer, J, i dr.
Izdano: (1992)

Inverse correlation of intact PTH, oxidized PTH as well as non-oxidized PTH with 25-hydroxyvitamin D3 in kidney transplant recipients
od: Jiao Zuo, i dr.
Izdano: (2023-05-01)

PTH analoga: vergelijkbaar of verschillend?
od: H. J. J. Verhaar, i dr.
Izdano: (2008-10-01)

Antagonizing microRNA‐19a/b augments PTH anabolic action and restores bone mass in osteoporosis in mice
od: Hanna Taipaleenmäki, i dr.
Izdano: (2022-10-01)

The Effects of Local Treatment of PTH(1-34) and Whitlockite and Hydroxyapatite Graft to the Calvarial Defect in a Rat Osteoporosis Model
od: Jiwoon Jeong, i dr.
Izdano: (2024-04-01)

Disruption of PTH receptor 1 in T cells protects against PTH-induced bone loss.
od: Hesham Tawfeek, i dr.
Izdano: (2010-08-01)

Update on the efficacy, safety, and adherence to treatment of full length parathyroid hormone, PTH (1-84), in the treatment of postmenopausal osteoporosis
od: Luca Pietrogrande
Izdano: (2009-11-01)

Intraoperative parathyroid hormone (PTH) testing in patients with primary hyperparathyroidism and PTH levels in the normal range
od: Fabio Medas, i dr.
Izdano: (2019-04-01)

The European Prospective Osteoporosis Study.
od: Reeve, J
Izdano: (1996)

Case Report: Inactivating PTH/PTHrP Signaling Disorder Type 1 Presenting With PTH Resistance
od: Tanguy Demaret, i dr.
Izdano: (2022-06-01)

Exploring the current and future role of the pharmacists in osteoporosis screening and management in Malaysia
od: Toh, Li Shean, i dr.
Izdano: (2018)

Study of Dental Caries and PTH Gene
od: Caio Luiz Bitencourt Reis, i dr.
Izdano: (2021-08-01)

On the characterization of least pth power derivations /
od: 325262 Lim, K. P.
Izdano: (1978)

Acetate free citrate-containing dialysate increase intact-PTH and BAP levels in the patients with low intact-PTH
od: Kuragano Takahiro, i dr.
Izdano: (2013-01-01)

Decrease in the expression of the type 1 PTH/PTHrP receptor (PTH1R) on chondrocytes in animals with osteoarthritis
od: Skwara Adrian, i dr.
Izdano: (2010-04-01)

Endogenous PTH deficiency impairs fracture healing and impedes the fracture-healing efficacy of exogenous PTH(1-34).
od: Yongxin Ren, i dr.
Izdano: (2011-01-01)

Design and topline results of TransCon PTH, a long-acting PTH, phase 2 trial in patients with hypoparathyroidism
od: David B. Karpf, i dr.
Izdano: (2020-10-01)

PTH Reloaded: A New Evolutionary Perspective
od: Paula Suarez-Bregua, i dr.
Izdano: (2017-10-01)

Effects of PTH on osteoblast bioenergetics in response to glucose
od: Victoria E. DeMambro, i dr.
Izdano: (2023-12-01)

Diagnosis of osteoporosis in clinical practice.
od: Kröger, H, i dr.
Izdano: (1998)

THE ROLE OF IL-17 AND TH17 CELLS IN THE BONE CATABOLIC ACTIVITY OF PTH
od: Roberto ePacifici
Izdano: (2016-02-01)

Childhood fractures do not predict future fractures: results from the European Prospective Osteoporosis Study.
od: Pye, SR, i dr.
Izdano: (2009)

Approximating the pth root by composite rational functions
od: Gawlik, ES, i dr.
Izdano: (2021)